Chemokines in Cancer Development and Progression and Their Potential as Targeting Molecules for Cancer Treatment
Chemokines were initially identified as bioactive substances, which control the trafficking of inflammatory cells including granulocytes and monocytes/macrophages. Moreover, chemokines have profound impacts on other types of cells associated with inflammatory responses, such as endothelial cells and...
Saved in:
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2014/170381 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832559050982686720 |
---|---|
author | Naofumi Mukaida So-ichiro Sasaki Tomohisa Baba |
author_facet | Naofumi Mukaida So-ichiro Sasaki Tomohisa Baba |
author_sort | Naofumi Mukaida |
collection | DOAJ |
description | Chemokines were initially identified as bioactive substances, which control the trafficking of inflammatory cells including granulocytes and monocytes/macrophages. Moreover, chemokines have profound impacts on other types of cells associated with inflammatory responses, such as endothelial cells and fibroblasts. These observations would implicate chemokines as master regulators in various inflammatory responses. Subsequent studies have further revealed that chemokines can regulate the movement of a wide variety of immune cells including lymphocytes, natural killer cells, and dendritic cells in both physiological and pathological conditions. These features endow chemokines with crucial roles in immune responses. Furthermore, increasing evidence points to the vital effects of several chemokines on the proliferative and invasive properties of cancer cells. It is widely acknowledged that cancer develops and progresses to invade and metastasize in continuous interaction with noncancerous cells present in cancer tissues, such as macrophages, lymphocytes, fibroblasts, and endothelial cells. The capacity of chemokines to regulate both cancerous and noncancerous cells highlights their crucial roles in cancer development and progression. Here, we will discuss the roles of chemokines in carcinogenesis and the possibility of chemokine targeting therapy for the treatment of cancer. |
format | Article |
id | doaj-art-08b5cb63514a43688d1aac70319c9040 |
institution | Kabale University |
issn | 0962-9351 1466-1861 |
language | English |
publishDate | 2014-01-01 |
publisher | Wiley |
record_format | Article |
series | Mediators of Inflammation |
spelling | doaj-art-08b5cb63514a43688d1aac70319c90402025-02-03T01:30:52ZengWileyMediators of Inflammation0962-93511466-18612014-01-01201410.1155/2014/170381170381Chemokines in Cancer Development and Progression and Their Potential as Targeting Molecules for Cancer TreatmentNaofumi Mukaida0So-ichiro Sasaki1Tomohisa Baba2Division of Molecular Bioregulation, Cancer Research Institute, Kanazawa University, Kakuma-machi, Kanazawa 920-1192, JapanDivision of Molecular Bioregulation, Cancer Research Institute, Kanazawa University, Kakuma-machi, Kanazawa 920-1192, JapanDivision of Molecular Bioregulation, Cancer Research Institute, Kanazawa University, Kakuma-machi, Kanazawa 920-1192, JapanChemokines were initially identified as bioactive substances, which control the trafficking of inflammatory cells including granulocytes and monocytes/macrophages. Moreover, chemokines have profound impacts on other types of cells associated with inflammatory responses, such as endothelial cells and fibroblasts. These observations would implicate chemokines as master regulators in various inflammatory responses. Subsequent studies have further revealed that chemokines can regulate the movement of a wide variety of immune cells including lymphocytes, natural killer cells, and dendritic cells in both physiological and pathological conditions. These features endow chemokines with crucial roles in immune responses. Furthermore, increasing evidence points to the vital effects of several chemokines on the proliferative and invasive properties of cancer cells. It is widely acknowledged that cancer develops and progresses to invade and metastasize in continuous interaction with noncancerous cells present in cancer tissues, such as macrophages, lymphocytes, fibroblasts, and endothelial cells. The capacity of chemokines to regulate both cancerous and noncancerous cells highlights their crucial roles in cancer development and progression. Here, we will discuss the roles of chemokines in carcinogenesis and the possibility of chemokine targeting therapy for the treatment of cancer.http://dx.doi.org/10.1155/2014/170381 |
spellingShingle | Naofumi Mukaida So-ichiro Sasaki Tomohisa Baba Chemokines in Cancer Development and Progression and Their Potential as Targeting Molecules for Cancer Treatment Mediators of Inflammation |
title | Chemokines in Cancer Development and Progression and Their Potential as Targeting Molecules for Cancer Treatment |
title_full | Chemokines in Cancer Development and Progression and Their Potential as Targeting Molecules for Cancer Treatment |
title_fullStr | Chemokines in Cancer Development and Progression and Their Potential as Targeting Molecules for Cancer Treatment |
title_full_unstemmed | Chemokines in Cancer Development and Progression and Their Potential as Targeting Molecules for Cancer Treatment |
title_short | Chemokines in Cancer Development and Progression and Their Potential as Targeting Molecules for Cancer Treatment |
title_sort | chemokines in cancer development and progression and their potential as targeting molecules for cancer treatment |
url | http://dx.doi.org/10.1155/2014/170381 |
work_keys_str_mv | AT naofumimukaida chemokinesincancerdevelopmentandprogressionandtheirpotentialastargetingmoleculesforcancertreatment AT soichirosasaki chemokinesincancerdevelopmentandprogressionandtheirpotentialastargetingmoleculesforcancertreatment AT tomohisababa chemokinesincancerdevelopmentandprogressionandtheirpotentialastargetingmoleculesforcancertreatment |